Hemostasis Gordon Research Conference (GRC): Defining the Interactions Between Blood, Cells, and Vessels in Hemostasis and Disease

Event Date: July 29 - August 3, 2018

Event Location: Waterville Valley Conference Center, 56 Packard's Road, Waterville Valley, NH 03215

hemostasis thrombosis chromogenic clotting assay test kit hemostasis thrombosis chromogenic clotting assay test kit hemostasis thrombosis chromogenic clotting assay test kit

Diapharma is planning to attend the Hemostasis Gordon Research Conference (GRC): Defining the Interactions Between Blood, Cells, and Vessels in Hemostasis and Disease meeting this year. Please click here to schedule a meeting with us or email us directly.

hemostasis thrombosis chromogenic clotting assay test kitAbout the GRC

The Hemostasis Gordon Research Conference (GRC) is a small scientific meeting on the topics of blood coagulation, platelet biology, anticoagulant pathways, and associated diseases. The Hemostasis GRC includes scientists interested in the biology, biochemistry, and genetics of platelets and coagulation proteins; physicians involved in the treatment of bleeding and thrombotic diseases; and investigators from small and large pharmaceutical/biotechnology companies developing new therapeutics and diagnostics for disorders of the hemostatic system. Topics at the Hemostasis GRC include novel and emerging aspects of hemostasis and thrombosis, as well as newly-identified roles for coagulation proteins, cells, and biophysical mechanisms in human disease.

GRC Topics

  • Initiating Events in Hemostasis and Thrombosis
  • Initiation of Contact Activation
  • Mechanisms of Platelet Alpha and Dense Granule Biogenesis
  • Contact Pathway Activation and Polyphosphate
  • Contributions from the Blood and Vasculature
  • Regulation of Endothelial Exocytosis
  • Fibrin/GPVI Interactions in Thrombosis and Hemostasis
  • Combining Immunohematology and Biophysics to Better Understand Immune-Mediated Blood Cell Disorders: Lessons Learned from HIT
  • A Chromosome 5 Cis-Regulatory Element Regulates Mouse Platelet PAI-1 Expression
  • Molecular Interactions Between Blood and Platelets
  • Genomic Approaches to von Willebrand Disease
  • Emerging Concepts in Immune-Mediated Thrombotic Thrombocytopenic Purpura
  • Platelet/Fibrin Interactions During Thrombosis
  • Cellular Contributions to Hemostasis and Thrombosis
  • Alterations in von Willebrand Factor and Redox State in Sickle Cell Disease
  • Zymogen Factor XII and Neutrophil Functions
  • The Dynamics of Protease Activated Receptor (PAR) Activation and Signaling
  • Role of VWF Glycans in Regulating Clearance
  • Mechanisms of Altered Platelet Production During Inflammation
  • Advanced Models of Coagulation
  • Insights into the Pathophysiology of Thrombosis Using Mice with Impaired Anticoagulation
  • Regulating Intra-Clot Thrombin and Fibrin Production Under Flow
  • Mathematical Models of Coagulation
  • Oral Therapy for Hemophilia
  • Novel Anticoagulants Through Allosteric Regulation of Coagulation Proteases
  • Targeting FXa with Aptamer-Small Molecule Active Site Inhibitor Pairs for Potent and Reversible AnticoagulationAssessing the Benefit of Emicizumab for the Treatment of Hemophilia A: From Lab to Label
  • Platelet-Like Particles for Hemostasis and Wound Repair
  • Coagulation Mechanisms Beyond Hemostasis
  • Mechanisms Coupling Hemostatic Factors to Tumorigenesis
  • The Role of Factor XIII-A in Energy Metabolism
  • Coagulation in Sickle Cell Disease
  • Role of Coagulation in Liver Injury and Repair
  • Gut Microbial Choline Metabolite TMAO Enhances Platelet Hyper-Reactivity and Thrombosis Risk
  • Hemostasis and Thrombosis: Bench to Bedside
  • Antithrombotic Therapy
  • Cellular Targets in Thrombosis

GRC | Facebook | Twitter | Instagram | Waterville Valley Resort Conference Center